1
|
Liu D, Pan JM, Pei X, Li JS. Interaction Between Apolipoprotein M Gene Single-Nucleotide Polymorphisms and Obesity and its Effect on Type 2 Diabetes Mellitus Susceptibility. Sci Rep 2020; 10:7859. [PMID: 32398715 PMCID: PMC7217861 DOI: 10.1038/s41598-020-64467-6] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2019] [Accepted: 03/31/2020] [Indexed: 11/24/2022] Open
Abstract
This study investigated the correlation of four single nucleotide polymorphisms (SNPs) in Apolipoprotein M (ApoM) with the risk of type 2 diabetes mellitus (T2DM) and effects of the interactions of this gene and obesity. The effects of SNP and obesity interaction on T2DM was examined by generalized multifactor dimensionality reduction (GMDR) combined with the logistic regression model. T2DM patient-control haplotype was analyzed in silico using the haplotype analysis algorithm SHEsis. The rs805296-C allele or 724-del allele indicted high risk of T2DM. The incidence of T2DM in individuals with rs805296-C allele polymorphism (TC + CC) was higher than those without (TT), adjusted OR (95%CI) = 1.29 (1.10–1.66) (p < 0.001). Moreover, the individuals with 724-delallele have a higher risk of T2DM compared to those with 724-ins variants, adjusted OR (95%CI) = 1.66 (1.40–2.06), p < 0.001. GMDR analysis suggested that the interaction model composed of the two factors, rs805296 and obesity, was the best model with statistical significance (P value from sign test [Psign]=0.0107). The T2DM risk in obese individuals having TC or CC genotype was higher than non-obese individuals with TT genotype (OR = 2.38, 95% CI = 1.58–3.53). Haplotype analysis suggests that rs805297-C and rs9404941-C alleles haplotype indicate high risk of T2DM, OR (95%CI) = 1.62 (1.29–2.16), p < 0.001. Our results suggested that rs805296 and 724-del minor allele of ApoM gene, interaction of rs805296 and obesity, rs805297-C and rs9404941-C alleles haplotype were indicators of high T2DM risk.
Collapse
Affiliation(s)
- Dan Liu
- Department of Endocrinology, The third people's Hospital of Hainan Province, Sanya, China.
| | - Jian-Min Pan
- Department of general surgery, The third people's Hospital of Hainan Province, Sanya, China
| | - Xiang Pei
- Department of Endocrinology, The third people's Hospital of Hainan Province, Sanya, China
| | - Jun-Sen Li
- Department of Endocrinology, The third people's Hospital of Hainan Province, Sanya, China
| |
Collapse
|
2
|
Ahmad A, Sundquist K, Zöller B, Dahlbäck B, Elf J, Svensson PJ, Strandberg K, Sundquist J, Memon AA. Evaluation of Expression Level of Apolipoprotein M as a Diagnostic Marker for Primary Venous Thromboembolism. Clin Appl Thromb Hemost 2017; 24:416-422. [PMID: 28914078 DOI: 10.1177/1076029617730639] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Recently, decreased levels of apolipoprotein M (ApoM) were shown to be associated with higher risk of recurrent venous thromboembolism (VTE) in male patients. However, the role of ApoM in primary VTE is unknown. We aimed in our study to analyze the plasma levels of ApoM in patients with VTE in order to evaluate the diagnostic importance of ApoM in primary VTE. A total of 357 patients with suspected first episode of VTE were recruited prospectively in the SCORE study. Plasma samples from 307 patients were available for quantifying the plasma levels of ApoM in patients with VTE using sandwich enzyme-linked immunosorbent assay method. Among the whole population, plasma levels (mean [standard deviation]) of ApoM were not significantly different between patients with VTE (0.72 [0.20]) and non-VTE patients (0.72 [0.16]), P = .99. Similarly, in regression analyses, no significant association of ApoM plasma levels with the risk of VTE was found on univariate (odds ratio [OR] =1.0, 95% confidence interval [CI] 0.21-4.84, P = .99) and multivariate analysis (OR = 1.25, 95% CI = 0.19-8.34, P = .819) after adjusting for age, body mass index, and smoking. Moreover, results did not differ significantly after stratification of data according to sex ( P > .05). In this study, our results do not suggest a diagnostic role for ApoM plasma levels in patients with primary VTE. Moreover, the current study suggests that role of ApoM as a risk factor may differ for primary VTE and recurrent VTE in male patients.
Collapse
Affiliation(s)
- Abrar Ahmad
- 1 Department of Clinical Sciences, Center for Primary Health Care Research, Skåne University Hospital, Lund University, Malmö, Sweden
| | - Kristina Sundquist
- 1 Department of Clinical Sciences, Center for Primary Health Care Research, Skåne University Hospital, Lund University, Malmö, Sweden.,2 Department of Family Medicine and Community Health, Department of Population Health Science and Policy, Icahn School of Medicine, Mount Sinai, New York, NY, USA
| | - Bengt Zöller
- 1 Department of Clinical Sciences, Center for Primary Health Care Research, Skåne University Hospital, Lund University, Malmö, Sweden
| | - Björn Dahlbäck
- 3 Department of Translational Medicine, Skåne University Hospital, Lund University, Malmö, Sweden
| | - Johan Elf
- 4 Vascular Centers, University Hospital Malmö, Lund University, Malmö, Sweden
| | - Peter J Svensson
- 5 Department of Coagulation Disorders, Skåne University Hospital, Lund University, Malmö, Sweden
| | - Karin Strandberg
- 6 Department of Clinical Chemistry, University Hospital, Lund University, Malmö, Sweden
| | - Jan Sundquist
- 1 Department of Clinical Sciences, Center for Primary Health Care Research, Skåne University Hospital, Lund University, Malmö, Sweden.,2 Department of Family Medicine and Community Health, Department of Population Health Science and Policy, Icahn School of Medicine, Mount Sinai, New York, NY, USA
| | - Ashfaque A Memon
- 1 Department of Clinical Sciences, Center for Primary Health Care Research, Skåne University Hospital, Lund University, Malmö, Sweden
| |
Collapse
|